LobbyingCoherus Biosciences lobbying by quarter
Coherus Biosciences's latest lobbying report covers Q2 2026, at $205K. The four quarters Q4 2025–Q3 2026 total $585K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Coherus Biosciences
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $585K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $465K | 6 |
| Q1 2023 | $465K | 6 |
| Q2 2023 | $475K | 7 |
| Q3 2023 | $475K | 7 |
| Q4 2023 | $365K | 7 |
| Q1 2024 | $177.5K | 5 |
| Q2 2024 | $162.5K | 5 |
| Q3 2024 | $105K | 3 |
| Q4 2024 | $110K | 2 |
| Q1 2025 | $110K | 2 |
| Q2 2025 | $220K | 3 |
| Q3 2025 | $225K | 3 |
| Q4 2025 | $190K | 3 |
| Q1 2026 | $190K | 3 |
| Q2 2026 | $205K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.5M · 47 reports
- Government issues$1.3M · 20 reports
- Medicare and Medicaid$449.2K · 27 reports
- Pharmacy$316.7K · 10 reports
- Defense$135K · 7 reports
- Intelligence and surveillance$135K · 7 reports
- Medical research and clinical labs$15K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE64 reports
- HOUSE OF REPRESENTATIVES62 reports
- Health & Human Services, Dept of (HHS)36 reports
- White House Office34 reports
- Defense, Dept of (DOD)22 reports
- Natl Security Council (NSC)20 reports
- Executive Office of the President (EOP)16 reports
- Centers For Medicare and Medicaid Services (CMS)15 reports
- Food & Drug Administration (FDA)15 reports
- Office of Management & Budget (OMB)15 reports
- Office of Science & Technology Policy (OSTP)15 reports
- Commerce, Dept of (DOC)10 reports
- Energy, Dept of9 reports
- Defense Advanced Research Projects Agency (DARPA)6 reports
- Defense Nuclear Facilities Safety Board6 reports
- Federal Emergency Management Agency (FEMA)6 reports
- President of the U.S.6 reports
- Vice President of the U.S.6 reports
- Homeland Security, Dept of (DHS)5 reports
- Export-Import Bank of the United States (EXIM Bank)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseCoherus Biosciences | $2.1M | 15 quarters |
| Inlet Strategies | $725K | 15 quarters |
| The McKeon Group | $315K | 8 quarters |
| Foley & Lardner | $250K | 5 quarters |
| Red+blue Strategies | $250K | 5 quarters |
| Capitol Hill Consulting Group | $200K | 5 quarters |
| Alston & Bird | $40K | 7 quarters |
| The Conafay Group | $30K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DAVID SANDERS | Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000) | Q2 2026 |
| JOHN STROM | Senior Counsel - U.S. House Cmte on Energy & Commerce; Counsel - U.S. Senate Cmte on Health, Education, Labor, and Pensions; Associate General Counsel - U.S. Dept of Health and Human Services; Senior Counsel - U.S. House Cmte on Natural Resources | Q2 2026 |
| KENDRA WHARTON | Associate Deputy Attorney General, United States Department of Justice. January 2025 - July 2005: Legislative Aide, Senator Mitch McConnell. May 2008 - November 2012 | Q2 2026 |
| THOMAS WHARTON | Legislative Assistant. Senator Lieberman May 2011-June 2012 Senior Legislative Assistant. Representative Dan Boren. July 2008-June 2011 | Q2 2026 |
| BEN KENNEY | CMS, HHS | Q2 2024 |
| BRYAN SHUY | Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmte on Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst. Secretary for Preparedness and Response (ASPR) | Q2 2024 |
| DARIN L GARDNER | Legislative Correspondent Senator Tim Hutchinson; Research Associate Senate HELP Committee; Chief of Staff Congresswoman Kay Granger | Q2 2024 |
| JOSH NARROW | Intern for Senator Casey | Q2 2024 |
| BRIAN SUTTER | Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02 | Q4 2023 |
| CHRISTOPHER DAVIS | Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011). | Q4 2023 |
| EMILY ELIZABETH WILKINSON-HOLLAND | Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19) | Q4 2023 |
| MARK RAYDER | LA, Rep. Tom Latham; LA, Rep. Rodney Frelinghuysen; District Rep., Rep. Dean Gallo. | Q2 2023 |
| EARL POMEROY | Congressman, U.S. House of Representatives | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/28for Q2 | In-house | $95K |
| 07/20for Q2 | Inlet Strategies | $60K |
| 07/19for Q2 | Foley & Lardner | $50K |
| 05/18for Q1 | In-house | $80K |
| 04/20for Q1 | Foley & Lardner | $50K |
| 04/19for Q1 | Inlet Strategies | $60K |
| 03/09for Q4 2025 | In-house | $80K |
| 01/19for Q4 2025 | Foley & Lardner | $50K |
| 01/18for Q4 2025 | Inlet Strategies | $60K |
| 25/10/22for Q4 2025 | In-house | $80K |
| 25/10/18for Q3 2025 | Foley & Lardner | $50K |
| 25/10/15for Q3 2025 | Inlet Strategies | $50K |
| 25/08/18for Q3 2025 | In-house | $125K |
| 25/08/18for Q2 2025 | In-house | $125K |
| 25/07/21for Q2 2025 | Foley & Lardner | $50K |
| 25/07/18for Q2 2025 | Foley & Lardner | Under $5,000 |
| 25/07/14for Q2 2025 | Inlet Strategies | $45K |
| 25/04/14for Q1 2025 | Inlet Strategies | $45K |
| 25/03/24for Q1 2025 | In-house | $65K |
| 25/03/24for Q4 2024 | In-house | $65K |